Ubs Group Ag Journey Medical Corp Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Journey Medical Corp stock. As of the latest transaction made, Ubs Group Ag holds 17,038 shares of DERM stock, worth $132,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,038
Previous 22,363
23.81%
Holding current value
$132,726
Previous $90,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DERM
# of Institutions
41Shares Held
5.89MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$14.4 Million0.71% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT931KShares$7.25 Million0.03% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.74 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA372KShares$2.9 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.338KShares$2.63 Million0.01% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $90.3M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...